TCHHL1
geneOn this page
Summary
TCHHL1 (trichohyalin like 1, HGNC:31796) is a protein-coding gene on chromosome 1q21.3, encoding Trichohyalin-like protein 1 (Q5QJ38).
This gene belongs to the S100 fused-type protein (SFTP) gene family, and is located in a cluster of SFTP genes on chromosome 1q21. Several members of this family have been implicated in the development of complex skin disorders. This gene is evolutionarily conserved; its expression appears to be hair-specific and spatially restricted within the distal inner root sheath of the hair follicle. It thus may have an important role in hair morphogenesis.
Source: NCBI Gene 126637 — RefSeq curated summary.
At a glance
- GWAS associations: 12
- Clinical variants (ClinVar): 119 total
- MANE Select transcript:
NM_001008536
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:31796 |
| Approved symbol | TCHHL1 |
| Name | trichohyalin like 1 |
| Location | 1q21.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000182898 |
| Ensembl biotype | protein_coding |
| Entrez | 126637 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000368806
RefSeq mRNA: 1 — MANE Select: NM_001008536
NM_001008536
CCDS: CCDS30857
Canonical transcript exons
ENST00000368806 — 3 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001447995 | 152084141 | 152087543 |
| ENSE00001447996 | 152088006 | 152088163 |
| ENSE00001447997 | 152089020 | 152089064 |
Expression profiles
Bgee: expression breadth tissue_specific, 4 present calls, max score 43.89.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0197 / max 14.5182, expressed in 5 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 14527 | 0.0197 | 5 |
Top tissues by expression
131 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| sural nerve | UBERON:0015488 | 43.89 | gold quality |
| bone marrow cell | CL:0002092 | 42.41 | gold quality |
| colonic epithelium | UBERON:0000397 | 41.36 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 41.01 | silver quality |
| placenta | UBERON:0001987 | 38.58 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 37.57 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| ganglionic eminence | UBERON:0004023 | 35.49 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 35.34 | gold quality |
| bone marrow | UBERON:0002371 | 34.94 | gold quality |
| muscle tissue | UBERON:0002385 | 34.14 | gold quality |
| tonsil | UBERON:0002372 | 31.63 | gold quality |
| monocyte | CL:0000576 | 31.11 | gold quality |
| leukocyte | CL:0000738 | 30.79 | gold quality |
| calcaneal tendon | UBERON:0003701 | 29.98 | gold quality |
| stromal cell of endometrium | CL:0002255 | 29.87 | gold quality |
| liver | UBERON:0002107 | 29.62 | gold quality |
| ectocervix | UBERON:0012249 | 29.19 | gold quality |
| prefrontal cortex | UBERON:0000451 | 29.04 | gold quality |
| uterine cervix | UBERON:0000002 | 28.46 | gold quality |
| duodenum | UBERON:0002114 | 28.14 | gold quality |
| islet of Langerhans | UBERON:0000006 | 27.88 | gold quality |
| lymph node | UBERON:0000029 | 27.57 | gold quality |
| blood | UBERON:0000178 | 27.33 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 27.31 | gold quality |
| right coronary artery | UBERON:0001625 | 26.79 | gold quality |
| skin of abdomen | UBERON:0001416 | 26.61 | gold quality |
| vermiform appendix | UBERON:0001154 | 26.42 | gold quality |
| gall bladder | UBERON:0002110 | 25.98 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 3.28 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
48 targeting TCHHL1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-6833-3P | 100.00 | 70.63 | 3197 |
| HSA-MIR-4768-5P | 100.00 | 69.49 | 2861 |
| HSA-MIR-4533 | 100.00 | 69.48 | 2758 |
| HSA-MIR-5011-5P | 100.00 | 83.46 | 5820 |
| HSA-MIR-3163 | 100.00 | 77.23 | 8605 |
| HSA-MIR-6077 | 99.99 | 68.04 | 2299 |
| HSA-MIR-4282 | 99.99 | 75.36 | 6408 |
| HSA-MIR-4745-5P | 99.98 | 65.95 | 1028 |
| HSA-MIR-3148 | 99.97 | 75.06 | 6478 |
| HSA-MIR-590-3P | 99.96 | 74.34 | 6478 |
| HSA-MIR-6715A-3P | 99.83 | 68.05 | 1473 |
| HSA-MIR-5010-3P | 99.83 | 70.60 | 2357 |
| HSA-MIR-944 | 99.82 | 70.85 | 3042 |
| HSA-MIR-4760-5P | 99.80 | 69.88 | 1619 |
| HSA-MIR-1255A | 99.74 | 68.09 | 744 |
| HSA-MIR-1255B-5P | 99.74 | 68.16 | 741 |
| HSA-MIR-4306 | 99.72 | 70.50 | 3630 |
| HSA-MIR-3177-5P | 99.65 | 70.38 | 1174 |
| HSA-MIR-651-5P | 99.64 | 68.49 | 1104 |
| HSA-MIR-8061 | 99.63 | 69.44 | 1411 |
| HSA-MIR-1275 | 99.47 | 67.90 | 2749 |
| HSA-MIR-3123 | 99.47 | 67.15 | 2693 |
| HSA-MIR-183-3P | 99.41 | 69.41 | 1598 |
| HSA-MIR-103A-1-5P | 99.39 | 67.78 | 1545 |
| HSA-MIR-103A-2-5P | 99.39 | 67.72 | 1577 |
| HSA-MIR-185-5P | 99.35 | 68.60 | 2497 |
| HSA-MIR-4644 | 99.35 | 69.12 | 2514 |
| HSA-MIR-4427 | 99.34 | 70.33 | 1854 |
| HSA-MIR-3678-3P | 99.31 | 67.10 | 1432 |
| HSA-MIR-6731-5P | 99.28 | 67.42 | 2375 |
Literature-anchored findings (GeneRIF, showing 3)
- We identified and characterized a novel S100 fused type protein expressed in hair follicles (PMID:21614011)
- These findings highlight the possibility that TCHHL1 proteins are expressed in growing keratinocytes of the epidermis and might be associated with the proliferation of keratinocytes. (PMID:23376073)
- Uncommon variants in FLG2 and TCHHL1 are associated with remission of atopic dermatitis in a large longitudinal US cohort. (PMID:34984527)
Cross-species orthologs
6 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Tchhl1 | ENSMUSG00000027908 |
| rattus_norvegicus | Tchhl1 | ENSRNOG00000009610 |
| drosophila_melanogaster | Cp190 | FBGN0000283 |
| drosophila_melanogaster | CG9915 | FBGN0030738 |
| drosophila_melanogaster | CG12592 | FBGN0037811 |
| caenorhabditis_elegans | WBGENE00008729 |
Paralogs (3): SAMD15 (ENSG00000100583), MDN1 (ENSG00000112159), IWS1 (ENSG00000163166)
Protein
Protein identifiers
Trichohyalin-like protein 1 — Q5QJ38 (reviewed: Q5QJ38)
Alternative names: Basalin, Protein S100-A17, S100 calcium-binding protein A17
All UniProt accessions (1): Q5QJ38
UniProt curated annotations — full annotation on UniProt →
Similarity. Belongs to the S-100 family.
RefSeq proteins (1): NP_001008536* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR011992 | EF-hand-dom_pair | Homologous_superfamily |
| IPR013787 | S100_Ca-bd_sub | Domain |
| IPR034325 | S-100_dom | Domain |
| IPR042937 | TCHHL1 | Family |
Pfam: PF01023
UniProt features (19 total): compositionally biased region 14, region of interest 2, chain 1, domain 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q5QJ38-F1 | 42.28 | 0.02 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 27 (showing top):
DARWICHE_PAPILLOMA_PROGRESSION_RISK, IVANOVA_HEMATOPOIESIS_EARLY_PROGENITOR, chr1q21, ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY, MIR944, MIR6833_3P, MIR4533, MIR4768_5P, MIR6077, MIR8085, MIR6731_5P, MIR6715A_3P, MIR3177_5P, MIR93_3P, MIR6804_5P
GO Biological Process (0):
GO Molecular Function (1): transition metal ion binding (GO:0046914)
GO Cellular Component (0):
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| metal ion binding | 1 |
Protein interactions and networks
STRING
1155 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| TCHHL1 | SPRR4 | Q96PI1 | 626 |
| TCHHL1 | S100A3 | P33764 | 626 |
| TCHHL1 | LELP1 | Q5T871 | 601 |
| TCHHL1 | S100A11 | P31949 | 572 |
| TCHHL1 | S100A2 | P29034 | 572 |
| TCHHL1 | S100A7L2 | Q5SY68 | 528 |
| TCHHL1 | CRNN | Q9UBG3 | 512 |
| TCHHL1 | LCE3C | Q5T5A8 | 499 |
| TCHHL1 | KPRP | Q5T749 | 484 |
| TCHHL1 | FLG | P20930 | 471 |
| TCHHL1 | KRT81 | Q14533 | 457 |
| TCHHL1 | RPF2 | Q9H7B2 | 455 |
| TCHHL1 | S100Z | Q8WXG8 | 450 |
| TCHHL1 | S100A4 | P26447 | 446 |
| TCHHL1 | SPRR3 | Q9UBC9 | 445 |
IntAct
3 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| TCHHL1 | PFN3 | psi-mi:“MI:0914”(association) | 0.350 |
| PPP4C | MID1 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (6): PFN3 (Affinity Capture-MS), SLC9A3R2 (Affinity Capture-MS), TCHHL1 (Affinity Capture-MS), TCHHL1 (Affinity Capture-MS), TCHHL1 (Cross-Linking-MS (XL-MS)), TCHHL1 (Co-fractionation)
ESM2 similar proteins: A0A1B0GTH6, A0A1B0GUW6, A0A1D5RMD1, A2AQH4, A4FU49, A6NJ88, C4P6S0, D3YU32, E9PAV3, F1QU13, I3L273, J3KML8, P70670, Q32L62, Q3V0E1, Q3V3Q4, Q4R729, Q5H9F3, Q5QJ38, Q5SWP3, Q5U4C1, Q5VWK0, Q5VYM1, Q68DN1, Q6AZ54, Q7TSG5, Q810T2, Q8CH19, Q8K4E0, Q8N3K9, Q8N5Q1, Q8NDH2, Q8TCU4, Q8WNU4, Q8WWL7, Q920R4, Q921B4, Q923B3, Q96JA4, Q96M34
Diamond homologs: A6QP92, P20930, P37709, P97347, Q07283, Q2VIS4, Q5D862, Q5QJ38, Q6XPR3, Q9D3P1, Q9UBG3, O77691, O77791, P02632, P02633, P02639, P04163, P05943, P05964, P06703, P07091, P08207, P14069, P22793, P23297, P24479, P25815, P27003, P29377, P30801, P31949, P31950, P35467, P56565, P60902, P60903, P62504, P79105, P80310, P80511
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
119 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 102 |
| Likely benign | 12 |
| Benign | 4 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
131 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 1:152088000:GCTCA:G | donor_loss | 1.0000 |
| 1:152088001:CTCA:C | donor_loss | 1.0000 |
| 1:152088002:TCAC:T | donor_loss | 1.0000 |
| 1:152088003:CAC:C | donor_loss | 1.0000 |
| 1:152088004:A:AG | donor_loss | 1.0000 |
| 1:152088005:CCT:C | donor_loss | 1.0000 |
| 1:152088161:AGG:A | acceptor_gain | 1.0000 |
| 1:152088162:GG:G | acceptor_gain | 1.0000 |
| 1:152088164:C:CC | acceptor_gain | 1.0000 |
| 1:152087539:CAGGG:C | acceptor_gain | 0.9900 |
| 1:152088160:GAGG:G | acceptor_gain | 0.9900 |
| 1:152088162:GGC:G | acceptor_loss | 0.9900 |
| 1:152088163:GC:G | acceptor_loss | 0.9900 |
| 1:152088164:C:A | acceptor_loss | 0.9900 |
| 1:152088166:G:C | acceptor_gain | 0.9900 |
| 1:152088166:G:GC | acceptor_gain | 0.9900 |
| 1:152089015:CTTA:C | donor_loss | 0.9900 |
| 1:152089017:TA:T | donor_loss | 0.9900 |
| 1:152089018:ACC:A | donor_loss | 0.9900 |
| 1:152089019:C:G | donor_loss | 0.9900 |
| 1:152087544:C:CC | acceptor_gain | 0.9800 |
| 1:152088027:G:A | donor_gain | 0.9800 |
| 1:152088159:AGAGG:A | acceptor_gain | 0.9800 |
| 1:152089018:A:AC | donor_gain | 0.9800 |
| 1:152089019:C:CC | donor_gain | 0.9800 |
| 1:152089019:CCTA:C | donor_gain | 0.9800 |
| 1:152089019:CCT:C | donor_gain | 0.9700 |
| 1:152089019:CCTAG:C | donor_gain | 0.9700 |
| 1:152089018:AC:A | donor_gain | 0.9600 |
| 1:152089019:CC:C | donor_gain | 0.9600 |
AlphaMissense
5937 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 1:152088099:G:C | F15L | 0.979 |
| 1:152088099:G:T | F15L | 0.979 |
| 1:152088101:A:G | F15L | 0.979 |
| 1:152087463:A:C | F73L | 0.970 |
| 1:152087463:A:T | F73L | 0.970 |
| 1:152087465:A:G | F73L | 0.970 |
| 1:152088037:A:G | L36P | 0.945 |
| 1:152087472:A:C | F70L | 0.939 |
| 1:152087472:A:T | F70L | 0.939 |
| 1:152087474:A:G | F70L | 0.939 |
| 1:152088046:A:G | L33P | 0.921 |
| 1:152088089:C:G | A19P | 0.917 |
| 1:152088100:A:G | F15S | 0.910 |
| 1:152087464:A:G | F73S | 0.890 |
| 1:152087448:G:C | F78L | 0.873 |
| 1:152087448:G:T | F78L | 0.873 |
| 1:152087450:A:G | F78L | 0.873 |
| 1:152088061:A:G | L28P | 0.863 |
| 1:152087461:A:T | V74D | 0.859 |
| 1:152088061:A:T | L28Q | 0.853 |
| 1:152088091:T:G | Y18S | 0.850 |
| 1:152088100:A:C | F15C | 0.843 |
| 1:152088037:A:T | L36H | 0.842 |
| 1:152087464:A:C | F73C | 0.840 |
| 1:152088112:A:T | V11E | 0.839 |
| 1:152088088:G:T | A19D | 0.838 |
| 1:152088092:A:C | Y18D | 0.835 |
| 1:152088133:A:G | L4P | 0.801 |
| 1:152087456:C:G | A76P | 0.798 |
| 1:152088061:A:C | L28R | 0.793 |
dbSNP variants (sampled 300 via entrez): RS1000788166 (1:152089580 G>A,T), RS1000828334 (1:152087027 T>C), RS1000971107 (1:152089352 A>G), RS1001676764 (1:152090551 G>T), RS1001796306 (1:152090476 T>C), RS1001833190 (1:152085006 CCT>C,CCTCT), RS1002625840 (1:152088878 G>A), RS1002678347 (1:152089157 A>G,T), RS1002900797 (1:152084304 A>G), RS1003530140 (1:152084553 T>C), RS1005028127 (1:152087734 C>A,T), RS1005970153 (1:152085639 A>C,G,T), RS1006261349 (1:152088486 G>A), RS1006788403 (1:152089589 GAA>G,GA,GAAA,GAAAA), RS1006813696 (1:152090907 A>C,G)
Disease associations
OMIM: gene `` | disease phenotypes: MIM:600057
GenCC curated gene-disease
Mondo (1): bladder exstrophy-epispadias-cloacal exstrophy complex (MONDO:0700039)
Orphanet (1): Classic bladder exstrophy (Orphanet:93930)
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
12 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST005191_11 | Hair shape | 2.000000e-82 |
| GCST005191_3 | Hair shape | 2.000000e-152 |
| GCST006661_183 | Male-pattern baldness | 1.000000e-10 |
| GCST007563_31 | Allergic disease (asthma, hay fever or eczema) | 2.000000e-08 |
| GCST007563_33 | Allergic disease (asthma, hay fever or eczema) | 3.000000e-11 |
| GCST007564_24 | Asthma or allergic disease (pleiotropy) | 5.000000e-12 |
| GCST007798_6 | Asthma | 2.000000e-20 |
| GCST008916_82 | Asthma | 5.000000e-27 |
| GCST008916_88 | Asthma | 1.000000e-25 |
| GCST009798_26 | Asthma | 2.000000e-21 |
| GCST010984_1 | Allergic disease (asthma, hay fever and/or eczema) (multivariate analysis) | 2.000000e-15 |
| GCST010985_38 | Allergic disease (asthma, hay fever and/or eczema) (age of onset) | 2.000000e-47 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004847 | age at onset |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
7 total (human), top 7 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| bisphenol A | decreases methylation | 1 |
| sodium arsenite | decreases expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Malathion | decreases expression | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
| Particulate Matter | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): bladder exstrophy-epispadias-cloacal exstrophy complex